Ian Burdick is a business strategist and biotech executive with a passion for regenerative medicine, advanced drug delivery, and biopharma innovation. As Director of Business Strategy at Solesis, he leads growth initiatives, M&A, and partnerships that drive transformative change in the industry. With a background spanning corporate strategy, product commercialization, and investment, Ian has played a key role in shaping markets and scaling technologies. Beyond his work, he serves on multiple advisory boards and is dedicated to mentoring startups and fostering innovation.